[EN] SUBSTITUTED N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS [FR] N-CYANOPYRROLIDINES SUBSTITUÉES AYANT UNE ACTIVITÉ EN TANT QU'INHIBITEURS DE L'USP30
摘要:
The present invention relates to a class of substituted N-cyanopyrrolidines with activity as inhibitors of the deubiquitylating enzyme USP30, having utility in a variety of therapeutic areas, including conditions involving mitochondrial dysfunction, cancer and fibrosis: Formula (I).
[EN] SUBSTITUTED N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS [FR] N-CYANOPYRROLIDINES SUBSTITUÉES AYANT UNE ACTIVITÉ EN TANT QU'INHIBITEURS DE L'USP30
摘要:
The present invention relates to a class of substituted N-cyanopyrrolidines with activity as inhibitors of the deubiquitylating enzyme USP30, having utility in a variety of therapeutic areas, including conditions involving mitochondrial dysfunction, cancer and fibrosis: Formula (I).
New compounds, pharmaceutical compositions and uses thereof
申请人:ROTH Gerald Juergen
公开号:US20120214785A1
公开(公告)日:2012-08-23
The invention relates to new compounds of the formula I
to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.
这项发明涉及到公式I的新化合物及其作为药物的用途,以及用于治疗的方法和含有这些化合物的药物组合物。
SUBSTITUTED HETEROARYL- AND ARYLALKYNYL BENZENE DERIVATIVES AS ACC-INHIBITORS FOR THE TREATMENT OF METABOLIC DISEASES